Pelcitoclax Uses, Dosage, Side Effects and more
Pelcitoclax is under investigation in clinical trial NCT04210037 (Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/refractory Small Cell Lung Cancer).
| Trade Name | Pelcitoclax |
| Generic | Pelcitoclax |
| Pelcitoclax Other Names | Pelcitoclax |
| Type | |
| Formula | C57H66ClF4N6O11PS4 |
| Weight | Average: 1281.84 Monoisotopic: 1280.303469 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
